Plant species used in giardiasis treatment: ethnopharmacology and in vitro evaluation of anti-Giardia activity  by Neiva, Vanessa do A. et al.
Rev Bras Farmacogn 24(2014): 215-224
* Corresponding author. 
 E-mail: flavia.amaral@ufma.br (F.M.M. Amaral).




Received 15 December 2013







A B S T R A C T
The aim of this study was to compile the traditional knowledge about plants used for the 
treatment of giardiasis, and also to carry out experimental research to evaluate the anti-
Giardia activity of five species. To reach this objective, 398 interviews were performed using a 
previously prepared questionnaire, followed by an in vitro evaluation of giardicidal potential 
of hydroalcoholic leaf extracts of Anacardium occidentale L., Chenopodium ambrosioides L., 
Passiflora edulis Sims, Psidium guajava L., and Stachytarpheta cayennensis (Rich.) Vahl. Among 
the interviewed people, 55.53% reported the use of plants to treat diarrhea, the most severe 
symptom of giardiasis. The results indicated 36 species used by this population for these 
problems. The use of leaves (72.50%) of a single plant (64.25%) collected from backyards 
and gardens (44.34%) and prepared by decoction were predominant. The majority of the 
interviewees (85.52%) attributed their cure to the use of plants. In the experimental tests, 
all extracts inhibited the growth of Giardia lamblia trophozoites in different intensities: 
A. occidentale and P. guajava extracts elicited a moderate activity (250 ≤ IC50 ≤ 500 μg/ml), 
C. ambrosioides and S. cayennensis extracts evoked a high activity (100 ≤ IC50 ≤ 250 μg/ml), 
and P. edulis extract showed very high activity (IC50 ≤ 100 μg/ml). This study shows that an 
ethnopharmacological approach is useful in the selection of plant materials with potential 
giardicidal activity.
© 2014 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editora Ltda. All rights reserved. 
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Introduction
Giardiasis is an intestinal infection caused by the flagellate 
protozoan Giardia lamblia (synonyms: Giardia intestinalis 
and Giardia duodenalis), with worldwide distribution, high 
prevalence, and significant morbidity (Rocha, 2003; Arani et 
al., 2008). Data from the World Health Organization report 
about 400 million new cases of G. lamblia infection per year 
(WHO, 2009). Since giardiasis is not a notifiable disease in 
Brazil, few prevalence records are available; however, several 
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epidemiological studies document infection rates of up to 
70.5%, indicating that it is a serious public health problem 
(Borges et al., 2011).
Clinical manifestations of giardiasis vary, however 
it’s most predominant symptom, diarrhea, occurrs in 
90% of symptomatic patients. Diarrhea can be acute and 
self-limiting, or chronic and debilitating, associated with 
abdominal pain, flatulence, dyspepsia, epigastric pain, 
nausea, vomiting, steatorrhea, low-lipid stools and fat-soluble 
vitamin absorption, and weight loss. The poor absorption 
of fats, carbohydrates, iron, and vitamins (A and B12) can 
delay physical and mental development, especially in 
younger individuals (Heresi et al., 2000; Lebwohl et al., 2003; 
Al-Mekhlafi et al., 2005).
The typical treatment for giardiasis is chemotherapy 
using one or more drugs, predominantly 5-nitroimidazole 
derivatives such as metronidazole, a first-line drug. Other 
nitroimidazoles (secnidazole, tinidazole, and ornidazole), 
benzimidazoles (albendazole, mebendazole), furazolidone, 
quinacrine, and benzimidazole derivatives have been used 
for giardiasis treatment. However, chemotherapeutic agents 
cause adverse reactions such as gastrointestinal disturbances, 
nausea, headache, leukopenia and parageusia; and may 
trigger neurotoxic effects as ataxia, seizures, and vertigo, 
leading to discontinuation of treatment. Moreover, mutagenic 
and carcinogenic effects have been observed in laboratory 
animals (Harris et al., 2001; Campanati and Monteiro-Leal, 
2002; Petri-Jr, 2003; Andrade et al., 2010). Because of the 
side effects of conventional drugs and an increased parasite 
resistance to treatment, it is necessary to identify new 
effective and safe agents for the treatment of this infection 
(Upcroft and Upcroft, 2001; Sangster et al., 2002, Hernández 
and Hernández, 2009).
Natural resources, especially of plant origin, are important 
sources of new bioactive products, considering the wide 
variety and complexity of metabolites with potential 
therapeutic value (Pinto et al., 2002; Anthony et al., 2005; 
Gurib-Fakim, 2006; Oliveira et al., 2011).
The assessment of therapeutic potential aimed at 
developing herbal or phytochemical products requires 
validation of the plant species through ethnobotanical, 
ethnopharmacological, chemical, biological, pharmacological, 
and toxicological studies (Gilani and Rahman, 2005; Macêdo 
and Oliveira, 2006; Klein et al., 2009). Ethnobotanical and 
ethnopharmacological studies have been shown to provide 
important findings in the search for new active products of 
plant origin, effectively contributing to defining the inclusion 
and exclusion criteria for the selection of plant species and 
their subsequent validation (Gilani and Rahman, 2005; 
Patwardhan, 2005; Albuquerque and Hanazaki, 2006).
Considering the high global prevalence of giardiasis 
and the need for new therapeutic options, taking into 
account the ethnopharmacological approach in the 
research and development of drugs of plant origin, an 
ethnopharmacological survey was conducted to identify 
the plant species traditionally used to treat giardiasis in the 
municipality of São Luís, Maranhão State, Brazil. Afterwards, 
validation studies for anti-Giardia activities of the plant 
species were conducted.
Materials and methods
The study was approved by the Ethics Committee of the 
Federal University of Maranhão under protocol number 
23115-012975/2008-43. Prior to data collection, the participants 
were asked to sign an informed consent form authorizing 
participation and dissemination of the data collected.
Ethnopharmacological study
Type of study
The first stage of the research was a descriptive, observational, 
and cross-sectional study. Structured and semi-structured 
interviews were used to collect ethnopharmacological data. 
The plants used traditionally by the study population were 
collected and identified. An experimental study was performed 
to assess the giardicidal activity in vitro of the extracts from 
the selected plants.
Study population
Data were collected from patients aged over 18 years and 
caregivers of children treated at a municipal public primary 
healthcare facility (Unit A) and private institution specializing 
indigestive system diseases (Unit B), both facilities located in 
the city of Sao Luis, Maranhão state, Brazil.
São Luís, the capital of Maranhão state, Brazil, located at 
2° 33c 00cc S and 44° 18c 00cc 19c W, has an area of 831.7 km2, 
an estimated 1,053,922 inhabitants, and population density of 
1215.69 inhabitants/km2 (IBGE, 2013).
On the basis of a previous ethnopharmacological giardiasis 
survey in São Luis, Maranhão, Brazil (Amaral, 2007), considering 
30% prevalence of plant use, 5% error, and 90% confidence 
interval, we surveyed 398 patients and/or caregivers as the 
study subjects.
Collection and analysis of ethnopharmacological data
To collect ethnopharmacological data, we used structured and 
semi-structured interviews with open and closed questions. 
Interviews were conducted from January to March 2011, 
and focused on the plant species used to treat diarrhea and 
dysentery.
This approach was chosen since people find it difficult to 
recognize giardiasis, but they can easily identify the plants 
used to treat diarrhea, the predominant giardiasis symptom 
that occurs in 90% of symptomatic patients (Lebwohl et al., 
2003; Al-Mekhlafi et al., 2005). Dysentery was the disorder used 
in the above approach because it was difficult for interviewees 
to differentiate diarrhea from dysentery.
The respondents that mentioned the use of plants were also 
questioned about the form(s) of preparation, plant part(s) used, 
origin of the plant material, source of information, knowledge 
about possible side effects and contraindications, as well as 
their socio-economic characteristics.
Collection and botanical identification
The species cited in the ethnopharmacological survey were 
collected from areas mentioned by the respondents, including 
urban landscapes (parks, squares, backyards, and vegetable 
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and medicinal gardens) and the countryside. The voucher 
specimens were deposited in the Ático Seabra Herbarium (SLS), 
of the Federal University of Maranhao, São Luis, MA, Brazil. The 
specimens were authenticated by Prof. Terezinha J. A. Rêgo.
Biological analysis
Selection of plant species
From the ethnopharmacological survey, Anacardium 
occidentale L., Anacardiaceae, Chenopodium ambrosioides L., 
Amaranthaceae, Passiflora edulis Sims, Passifloraceae, Psidium 
guajava L., Mystaceae, and Stachytarpheta cayennensis (Rich.) 
Vahl, Verbenaceae, were selected to assess their giardicidal 
activity in vitro. The inclusion criteria were as follows: the 
plants most frequently used to treat diarrhea and dysentery; 
whether they were native or exotic, and if they had a wide 
distribution in the region. The exclusion criteria included: toxic 
plants, with validated giardicidal activity, endangered and/or 
not cultivated in the region.
Preparation of extracts
Leaves of A. occidentale, C. ambrosioides, P. edulis, P. guajava, 
and S. cayennensis were collected manually from their natural 
habitats, in the city of São Luís, Maranhão state, from May to 
July 2011.
The plant material of each species were dried separately 
in an air circulation oven at a temperature of 38°C, and then 
ground in a Wiley mill to obtain a moderately coarse powder 
(250-710 μm). The  A. occidentale (70 g), C. ambrosioides (75 g), 
P. edulis (75 g), P. guajava (68 g), and S. cayennensis (72 g) plant 
material was extracted by maceration and percolation using 
70% ethanol for a period of 15 days (in 3-day intervals) for both 
extractive processes.
The extraction solutions were concentrated under 
reduced pressure in a rotary evaporator. The dry residue was 
re-suspended in pH 7.2 phosphate buffered solution (PBS) to 
a final concentration of 5 mg/ml, or previously solubilized 
in dimethyl sulfoxide (DMSO) with a limit of 0.1% (Gillin et 
al., 1982). All solutions were sterilized by filtration through a 
0.22-μm membrane, and stored in sterile bottles at 4 °C until 
analysis.
Evaluation of in vitro anti-Giardia activity
Axenic strains of G. lamblia (Portland-1; ATCC 30888) were 
maintained in TYI-S-33 medium in glass tubes, enriched with 
bovine bile and supplemented with inactivated bovine serum, 
at 37°C (Diamond et al., 1978; Keister, 1983). For maintenance 
and preservation of the strains, the cultures were examined 
daily under an inverted microscope to check the growth, 
activity, and degree of adherence of trophozoites to the tube 
walls. Subculturing was performed every 96 h, corresponding 
to the exponential phase of growth (Rocha, 2003; Amaral, 2007).
The giardicidal activity in vitro test was performed as 
described previously (Cedillo-Rivera and Munoz, 1992; Cedillo-
Rivera et al.1992; Calzada et al., 1999), with modifications 
(Amaral, 2007). Aliquots of the stock solutions of leaf extracts 
of A. occidentale, C. ambrosioides, P. edulis, P. guajava, and S. 
cayennensis (5 mg/ml) were added to 1.5 ml Eppendorf® tubes 
and serially diluted in TYI-S-33 modified medium to final 
concentrations of 500, 100, 20, and 4 μg/ml. An inoculum 
containing 5 × 103 trophozoites/ml from a logarithmic growth 
phase culture was distributed in 1.5-ml Eppendorf® tubes.
After 72 h of incubation at 37°C quantitative evaluations 
were performed by indirect method (colorimetric method / 
MTT). The tests included a positive control (metronidazole) 
and negative control (TYI-S-33 and/or DMSO).
Statistical analysis
The ethnopharmacological data were formatted and analyzed 
using SPSS 18.0 for Windows, with descriptive analysis of data 
and presentation of frequency tables, followed by analysis 
using Fisher’s exact test and F2 test of independence, with a 
significance level (D) of 5%.
In the evaluation of the in vitro giardicidal activity, the 
results were expressed as the growth inhibitory concentration 
(IC50), calculated by linear regression using the GraphPad Prism 
5.0 program. All samples were tested in triplicate and the 
experiments were performed twice (n = 6).
Results and discussion
In order to gain knowledge about plants widely used to treat 
Giardia infection, we focused our study on plants used against 
diarrhea and dysentery. 
This study included 262 women (65.83%) and 136 men 
(34.17%). We interviewed 211 participants in Unit A and 187 
in Unit B. We noted 55.53% prevalence for the use of plants 
for medicinal purposes. Although results shows a lower 
prevalence of use of plants compared to a previous study by 
Amaral (2007) (76.25%) also in São Luís, MA,  the amount of 
plants observed in our sample is still considered high. It is 
noteworthy  that respondents in Unit B, who were from a 
private health care institution with accredited/or private health 
care plans, used medicinal plants even though their prevalence 
rate was expected to be lower in this study than the reported 
in the above-mentioned report.
Considering that the area where this study was carried 
out is classified as a micro-region of a large urban cluster, the 
high percentage of plant users is surprising. Nevertheless, this 
finding is in accordance with the study of Camargo (2003), 
which reports that “medicinal plants” and “herbal remedies” 
are used by both urban and rural population, to a different 
extent, depending on the cultural environment.
The sample consisted of an adult population with an 
average age above 48 years old. The survey showed that 
the majority of respondents (75.12%) had at least complete 
secondary education. The economic profile of the respondents 
was determined using the economic classification criteria 
adopted by the Brazilian Association of Research Companies 
(ABEP, 2012), which showed that the majority of individuals 
belonged to class B (42.71%) and C (42.21%) of this classification 
(Table 1).
In the studied population sample, gender, education, and 
socio-economic status were statistically significant factors 
for the use of plants (p < 0.05) (Table 1). The prevalence of 
plant use by women for treating diarrhea and dysentery in 
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this study may be explained by their role in the cultural and 
traditional representation of health and familial disease 
(Medeiros and Cabral, 2001; Almassy, 2004; Budó et al., 
2008), as well as their therapeutic knowledge (Borba and 
Macedo, 2006) result of their important role as caregivers.
The frequency of plant use by elders demonstrated 
in this study is in agreement with the results of several 
national ethnopharmacological studies, reflecting the 
tendency of the accumulation of knowledge by this group, 
given the cultural preservation and traditional use of plants 
as a therapeutic resource. The high percentage of plant 
use among the elderly deserves attention, and health 
professionals should be able to guide its safe and rational 
use, minimizing the risk and dangers of this practice (Gama 
and Silva, 2006).
With regard to education level, the data of our study 
show that 31.41% of the respondents completed high 
school. This high prevalence of plant use in individuals 
Variables
Use of plants to treat diarrhea and dysentery
Total
No Yes
n % n % n %
Gendera
Female 103 39.31 159 60.69 262 65.83
Male 74 54.41 62 45.59 136 34.17
Total 177 44.47 221 55.53 398 100.00
Ageb (years)
18–27 35 76.09 11 23.91 46 11.56
28–37 37 63.79 21 36.21 58 14.57
38–47 32 42.67 43 57.33 75 18.84
48–57 40 36.04 71 63.96 111 27.89
> 57 33 30.56 75 69.44 108 27.14
Total 177 44.47 221 55.53 398 100.00
Education
Incomplete primary school 26 59.09 18 40.91 44 11.06
Complete primary school 21 36.21 37 63.79 58 14.57
Incomplete secondary school 28 38.89 44 61.11 72 18.09
Complete secondary school 51 40.80 74 59.20 125 31.41
Incomplete university 11 37.93 18 62.07 29 7.29
Complete university 35 59.32 24 40.68 59 14.82
Post-graduate 5 45.45 6 54.55 11 2.76
Total 177 44.47 221 55.53 398 100.00
Economic classa
A 19 61.29 12 38.71 31 7.79
B1 40 57.14 30 42.86 70 17.59
B2 33 33.00 67 67.00 100 25.12
C1 46 42.20 63 57.80 109 27.39
C2 28 47.46 31 52.54 59 14.82
D 11 37.93 18 62.07 29 7.29
Total 177 44.47 221 55.53 398 100.00
n = 398, F2 Independence test.  
ap < 0.05. 
bp < 0.001.
Table 1
Socio-economic and demographic data (gender, age, education level and social class) of the selected users of healthcare services 
from São Luis, Maranhão, Brazil, and their knowledge regarding medicinal plants used to treat diarrhea and dysentery.
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with high education levels differs from other studies 
(Amaral, 2007; Pessoa and Cartágenes, 2010; Almeida et 
al., 2012), yet this data agrees with the study performed 
by Vieira (2011). Nevertheless, a higher education level of 
the respondents may reflect a greater purchasing power. 
It must be taken into consideration that the survey was 
conducted in a private health institution (Unit B), which 
may be indicative of the increased interest in phytotherapy 
in recent years (Borba and Macedo, 2006), as well as the 
implementation of the National Policy on Medicinal Plants 
and Phytopharmaceuticals (Decree 5.813/06) (Ministério da 
Saúde, 2006) and the National Policy on Integrative and 
Complementary Practices at the SUS (Public Health System) 
(Anvisa, 2006) expanded and globalized their access.
The economic profile of the respondents casts the 
economy from Maranhão as a Brazilian state with a low 
per capita income (IBGE, 2013), which is also in agreement 
with the study by Amaral (2007). 
The plant material data indicated that the use of the 
leaves (72.5%) prepared by decoction predominated 
(49.32%), followed by infusion (32.58%), steeping (13.13%), 
and as syrup (4.98%). The predominance of leaf use can be 
explained by the belief that there is a greater concentration 
of the active ingredients in this plant part (Gonçalves 
and Martins, 1998), availability  at all times of the year in 
most biomes and/or ease of harvesting (Castellucci et al., 
2000). However, it is important to identify and select the 
correct part of the plant, since the distribution of active 
componds responsible for the expected therapeutic effect 
may vary between organs according to the species (Pinto 
and Santiago, 2000; Calábria, 2008).
The frequent use of decoction is observed in several 
ethnopharmacological studies. Oliveira et al. (2010) 
correlated the predominant mode of preparation and 
the use of heat, to assess the efficacy of the preparations 
obtained. Mosca and Loiola (2009) reported the practicality 
and speed of the preparation methods. Badke (2008) found 
that people considered baking as the best way to extract the 
chemicals that elicit healing properties, especially when a 
dry plant is used. However, the observation that heating is 
commonly used in homemade plant preparations shows 
a lack of knowledge about the losses and/or metabolic 
changes in the plant caused by the rise in temperature 
(Pascarelli et al., 2006), which demonstrates the need for 
guidance on the correct preparation of plant extracts.
Backyards and home gardens were the predominant 
places (44.34%) from which the plants were collected, 
followed by pharmacies (21.72%), markets and fairs (18.55%), 
and other areas (15.38%). Our findings are consistent with 
those of other local ethnopharmacological studies (Amaral 
et al., 2001; 2002; Pessoa and Cartágenes, 2010; Vieira, 
2011; Silva, 2012). Nevertheless, we observed significantly 
more purchases in pharmacies compared with the results 
shown by Amaral (2007), which can be explained by a noted 
increase of commercially available natural products in the 
past years (unpublished data).
Our data on the number of plant species used during 
treatment show that the majority of people (64.25%) used 
single species in their preparations. When asked about 
plants used along with synthetic drugs, the majority of 
respondents (53.39%) specified that they used only plants. 
The result was similar to that by Amaral (2007), showing 
that although both studies were conducted in urban areas 
with greater access to allopathic medicines, the use of a 
single plant species not predominates.
Although studies confirm mixing plants for medicinal 
use is common practice in different cultures (Ming and 
Amaral Junior, 2003; Calábria et al., 2008; Veiga Junior, 2008), 
the scientific consensus points the lack of pharmacological 
studies regarding plant-plant and plant-synthetic drug 
interactions, and the harmful effects already observed and 
attributed to such associations (Albuquerque and Andrade, 
2002; Albuquerque and Hanazaki, 2006; Oliveira and Dalla 
Costa, 2004; Arnous et al., 2005; Nicoletti et al., 2007; Veiga 
Junior, 2008).
Information obtained from relatives was the primary 
source of knowledge of plants used to treat diarrhea and 
dysentery (62.44%), followed by healers (18.55%), the media 
(15.38%), and health professionals (3.62%).
When asked about the credibility of treating diarrhea 
and dysentery using plants, the majority (85.52%) attributed 
the healing to herbal use. When questioned about their 
knowledge of the hazards or risks of using plants as a 
therapeutic resource, the majority of respondents (91.40%) 
indicated that they were not aware of risks.
The lack of knowledge on the hazards and risks of 
using plants as a therapeutic resource among respondents 
is worrying. This finding coupled with the fact that most 
plants available for therapeutic purposes in Brazil have not 
been validated, the poisoning potential of  known toxic 
plants and poisoning because of the use of plant material 
of poor quality, either by inadequate dosage, identification, 
cultivation method, harvesting, storage, preservation, 
and preparation (Matos, 2000; Araújo and Ohara, 2000); 
processes that require the involvement of supervisory 
bodies, with a strong commitment with pharmacovigilance 
in phytotherapy (Silveira et al., 2008).
Among the plants most frequently mentioned by the 
respondents, 33 were identified by species and three 
by genus, and they were distributed in 26 families, 
predominantly Myrtaceae, Anacardiaceae, Lamiaceae, 
Verbenaceae, and Asteraceae (Table 2).
The species most frequently cited by the respondents 
for the treatment of diarrhea and dysentery are Allium 
sativum L., A. occidentale L., Baccharis trimera (Less) DC., 
Jacaranda decurrens Cham., Bixa orellana L., C. ambrosioides 
L., Momordica charantia L., Eleutherine plicata Herb., Mentha 
spp., Musa spp., P. guajava L., Averrhoa carambola L., P. edulis 
Sims., Oryza sativa L., Malus spp., and Citrus sinensis (L.) 
Osbeck (Table 2). Regarding these species, we noted that 
many plants identified in our study were also cited by 
other ethnobotanical and/or ethnopharmacological studies 
developed in different regions from Brazil, highlighting A. 
occidentale L. (Calábria et al., 2008; Pinto, 2008; Oliveira et al., 
2010), Eleutherine plicata Herb. (Martins et al., 2005; Vallinoto 
et al., 2007), P. guajava L. (Vallinoto et al., 2007; Calábria 
et al., 2008; Oliveira, 2008; Pinto, 2008; Oliveira et al., 
2010; Niehues et al., 2011; Nóbrega et al., 2011), Byrsonima 
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Family Botanical name Regional vernacular name Vouchernumber Part used Citations (N)
a
Alliaceae Allium sativum L. alho 0996/SLSb bulb 102
Anacardiaceae Myracrodruon urundeuva Fr. All
























Arecaceae Orbignya phalerata Mart. babaçu 1022/SLS fruit mesocarp 84
Asteraceae accharis trimera (Less)
Matricaria chamomilla L. 













Bignoniaceae Jacaranda decurrens Cham. carobinha 1140/ SLS leaf/ bark 141
Bixaceae Bixa orellana L. urucum 0815/SLS seed 98
Chenopodiaceae Chenopodium ambrosioides L. mastruz 1148/SLS leaf 149
Cucurbitaceae Jacaranda decurrens Cham. carobinha 1140/ SLS leaf/ bark 141
Equisetaceae Equisetum giganteum L. cavalinha 1501/SLS leaf 53
Euphorbiaceae Jatropha gossypiifolia L. 










Fabaceae Caesalpinia férrea Mart. jucá 0834/SLS stem bark 36
Iridaceae Eleutherine plicata Herb. coquinho 1131/SLS leaf/stem 183










Malpighiaceae Byrsonima variabilis A. Juss murici 1274/SLS leaf 19
Malvaceae Gossypium hirsutum L. algodoeiro 1115/SLS leaf/seed 75
Musaceae Musa spp. banana 1091/SLS leaf/fruit 212















Nyctaginaceae Boerhavia diffusa L. pega-pinto 1070/SLS root 56
Oxalidaceae Averrhoa carambola L. carambola 0561/SLS leaf 109
Passifloraceae Passiflora edulis Sims. maracujá 1155/SLS leaf 115
Poacea Oryza sativa L. arroz 1095/SLS seed 202
Rosaceae Malus spp. maçã 1497/SLS fruit 206
Rubiaceae Spermacoce verticillata L. vassourinha-de-botão 1493/SLS aerial part 54
Rutaceae Citrus sinensis (L.) Osbeck. laranja 1014/SLS fruit 101
Verbenaceae Lippia alba (Mill) N. E. Brown. erva-cidreira 1122/SLS leaf 89
Stachytarpheta cayenensis 
(L.C.Rich.) Vahl
gervão 1081/SLS leaf 106
aThe interviewees referred to more than one plant for the treatment of diarrhea and dysentery. 
bÁticoSeabra Herbarium (SLS) of the Federal University of Maranhão, São Luis, MA, Brazil.
Table 2
Plants used by the respondents interviewed in health facilities in São Luís, Maranhão, Brazil, for the treatment of diarrhea and 
dysentery as classified by family, regional vernacular name, voucher number, part used, and number of citations.
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verbascifolia Rich ex. Juss (Agra et al., 2007; Boscolo and 
Valle, 2008; Oliveira et al., 2010), Eugenia uniflora L. (Calábria 
et al., 2008; Costa and Nunes, 2010), and Lippia alba (Mill) 
N. E. Brown. (Calábria et al., 2008; Oliveira, 2008; Oliveira 
et al., 2010; Tavares et al., 2011).
However, we found that some of the referred species such 
as Allium sativum L., Annona squamosa L., Caesalpinia ferrea 
Mart., C. ambrosioides L., Hymenaea courbaril L., Mentha spp., 
Momordica charantia L., Ocimum basilicum L., and S. cayenensis 
(Rich.) Vahl (Table 2) have been reported for the treatment 
of intestinal parasites and gastrointestinal disorders. These 
health hazards are frequently accompanied by symptoms 
like diarrhea and dysentery, and therefore may represent 
a use agreement.
The relative IC50 values of hydroalcoholic leaf extracts 
of A. occidentale, C. ambrosioides, P. edulis, P. guajava, and S. 
cayennensis obtained by maceration and percolation on the 
growth of G. lamblia trophozoites were determined using an 
indirect cell quantification method (Table 3).
The results show that all extracts of the selected 
species had an inhibitory effect on the growth of G. lamblia 
trophozoites. According to the classification criteria 
established by Amaral et al. (2006), the in vitro giardicidal 
activity was moderate for A. occidentale and P. guajava (250 ≤ 
IC50 ≤ 500 μg/ml), high for C. ambrosioides and S. cayennensis 
(100 ≤ IC50 ≤ 250 μg/ml), and very high for P. edulis (IC50 ≤ 
100 μg/ml). The extraction method did not influence the 
giardicidal activity IC50 values (Table 3).
A study performed using extracts rich in polyphenols 
showed significant giardicidal activity attributed to these 
metabolites (Anthony et al., 2011); and, according to Trabulsi 
Filho et al. (2013), the extract of A. occidentale studied in this 
paper has polyphenols as major constituents. Thus, these 
compounds may be probably considered responsible for the 
moderately active giardicidal properties found in this study.
An in vitro  giardicidal evaluation of a methanolic 
extract of the aerial parts of C. ambrosioides collected in 
Mexico indicated an IC50 of 116.10 μg/ml (Calzada et al., 
2006). Our evaluation of the in vitro giardicidal activity of a 
hydroalcoholic extract of the leaves of this species collected 
in São Luís, Maranhão state, showed an IC50 from 198.18 
to 214.16 μg/ml. Thus, on the basis of the criteria adopted 
in this study, our study confirmed the in vitro giardicidal 
activity for the species. The difference in trophozoite 
growth inhibition in these two studies may be related to 
variables that interfere with the synthesis of secondary 
metabolites, the place and time of collection, the age of 
the plant, the solvent used, the strain of G. lamblia, and 
the test model.
We did not find any studies on the anti-parasitic, 
especially anti-Giardia, activity of P. edulis and/or other 
species of Passifloraceae. However, our results showing IC50 
from 75.13 to 77.28 μg/ml may result from the presence 
of flavonoids, especially rutin and luteolin glycosides, 
chemical constituents with anti-Giardia  activity, as 
described in other species (Calzada et al., 2001; 2003; 2005).
The extracts of P. guajava assessed in this study showed 
a moderate activity, but a study by Ponce-Macotela et al. 
(1994) indicated giardicidal potential of this species. This 
difference in the cytotoxicity profile may be the result of 




maceration 378.88 ± 19.63a
percolation 399.23 ± 21.13a
Chenopodium ambrosioides L.
maceration 214.16 ± 5.02a
percolation 198.18 ± 4.28a
Passiflora edulis  Sims.
maceration 77.28 ± 1.52a
percolation 75.13 ± 1.41a
Psidiumguajava L.
maceration 457.91 ± 25.06a
percolation 439.83 ± 24.11a
Stachytarpheta cayennensis (Rich.) Vahl.
maceration 120.93 ± 2.54a
percolation 118.75 ± 2.50a
aResults are expressed as the mean number of viable Giardia lamblia trophozoites ± standard deviation (SD) in hydroalcoholic extracts of 
Anacardium occidentale, Chenopodium ambrosioides, Passiflora edulis, Psidium guajava, and Stachytarpheta cayennensis leaves obtained by maceration 
and percolation with hydromodule ratios of 1:6, 1:5, 1:8, 1:5, and 1:5, respectively. Metronidazole (IC50 0.22 μg/ml) was used as a positive control. 
Identical letters indicate equal values.
Table 3
In vitro activity against Giardia lamblia trophozoites (Portland 1 strain, ATCC 30888), expressed as relative growth inhibitory 
concentration (IC50) values of the hydroalcoholic extracts of the leaves of Anacardium occidentale L., Chenopodium ambrosioides L., 
Passiflora edulis Sims., Psidium guajava L., and Stachytarpheta cayennensis (Rich.) Vahl. obtained by maceration and percolation.
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variables between the studies. Studies performed by Calzada 
et al. (1999; 2005) showed that the flavonoid quercentin, 
isolated from different species, has high giardicidal activity, 
thus , the presence of flavonoids in P. guajava, may likely 
explain the activity found in these studies.
Moreira et al .  (2007) showed the leishmanicidal 
activity of hydroalcoholic extracts of dried leaves of S. 
cayennensis against Leishmania braziliensis and Leishmania 
amazonensis promastigotes. Another study by Ordóñez 
al. (2001) documented the in vitro giardicidal activity 
of hydroalcoholic extract of Stachytarpheta jamaicensis 
(L.) Vahl., with proven growth inhibition of G. lamblia 
trophozoites, compared with other species of the family 
Verbenaceae (Tapia-Pérez et al., 2003; Calzada et al., 2006; 
Ponce-Macotela et al., 2006). Our analysis of the giardicidal 
activity of S. cayennensis, along with the evidence of anti-
protozoan activity in other in vitro studies using species of 
the same genus and family, is indicative of the contribution 
of a chemotaxonomic approach as a valid strategy in the 
search for bioactive substances, which should stimulate 
further studies.
The selection of plant species for anti-Giardia activity 
validation studies, based on an ethnopharmacological 
approach is useful in the search for new therapies to 
combat the disease with a marked morbidity in the region.
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